脑部放疗，上午比下午敏感许多！. F) ?' g$ g5 d" x' _
, J6 ~- V5 p- P; {9 x1 m7 j0 e
$ @0 y. V2 m/ Z, [6 C7 J
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
; O0 E! ^5 p9 i: A1 ]7 mGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
! P* J# n `/ l" U% |Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.$ f1 x. h/ p# i9 T% x N
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
: b: d& q# K% U$ W6 V2 C. f9 C4 @4 G D7 ]
Abstract
/ N% o1 y& u* M% \ N+ ?3 |# \BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time. O6 ~, q# q$ p# |' x9 c
$ p! [) ]+ j9 v" `9 D O: h+ w9 I( RMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.- |. o3 s. s! B" l* @6 k
; z) H- }, n' z. U9 k% URESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).4 R% P8 G+ _" s5 Q
" u2 Q, u1 ?8 p$ @; y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.! K- z! j7 v7 G" W6 r! b1 Q5 D h; p
1 G; N& k, i1 A: d
|
显身卡
